Jun 21, 2019 / 07:30AM GMT
Operator
Good morning, ladies and gentlemen, and thank you for standing by. Welcome to today's Valneva Conference Call. (Operator Instructions) I must also advise you that this conference is being recorded today, Friday, the 21st of June 2019.
And I would now like to hand the conference over to your speaker today, Thomas Lingelbach. Please go ahead.
Thomas Lingelbach - Valneva SE - Chairman of the Management Board, President & CEO
Thanks a lot. Good morning, ladies and gentlemen. Yesterday evening, we announced major strategic decision and step for Valneva. We announced the mutual agreement with GSK to end our Strategic Alliance Agreement and by doing so regaining full control of our own R&D activities. We spoke to a couple of our key institutional investors yesterday evening already and got quite positive feedback on our decision, and as such, we are pleased to present to you today why we have decided to do so and what it means for Valneva and its strategic development going forward.
As you may recall, the Strategic Alliance Agreement was
Valneva SE to Announce Agreement with GlaxoSmithKline PLC to End Strategic Alliance Agreement Call Transcript
Jun 21, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers